Overview

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

Status:
Withdrawn
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the response rate of desmoid tumors to hydroxyurea. The investigators hypothesize that hydroxyurea will be a safe, non-toxic alternative to aggressive surgery or chemotherapy for this difficult to treat tumor.
Phase:
Phase 2
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Treatments:
Hydroxyurea